Stanford University has launched the DM Biobank to provide high-quality DM biological samples to researchers around the world. By participating in the Biobank, DM community members can play an important role in the development of new therapies that may help patients today and for generations to come.
A recently published study from Sweden reported impaired facial recognition in people with DM1 and indicated that there are brain differences that affect how faces are perceived and stored by people with DM1.
SAN FRANCISCO, CA (March 28, 2014): The Myotonic Dystrophy Foundation (MDF) has published the results of its first-ever Fund-a-Fellow Program Assessment measuring the impact of the first five years of its post-doctoral fellowship grant program.
Matthew Disney, PhD, associate professor in the Department of Chemistry at The Scripps Research Institute in Florida, has been working with a talented research team in his lab on a number of projects, including one studying how small molecules may target toxic RNA folds in DM2.
Dr. Richard Moxley, Director of the Wellstone Muscular Dystrophy Cooperative Research Center at the University of Rochester and a global leader in DM clinical care and research recently talked with MDF about his long and exceptionally distinguished career in neurology.